OBJECTIVE: To compare the prevalence of tinnitus in temporomandibular disorder (TMD) patients affected by either jaw muscle pain, temporomandibular joint (TMJ) internal derangements, or TMJ arthrosis. METHODS: The presence of self-reported tinnitus was assessed in 250 consecutive TMD patients and correlation analysis was performed with clinical TMD signs and symptoms. RESULTS: Tinnitus prevalence in the TMD population was 30.4%. Any significant patterns of correlation were shown for the overall study group, despite a higher tinnitus prevalence in patients with (32.8%) than without masseter pain (24.8%; p = 0.176) as well as in those with (33.7%) than without TMJ arthrosis (26.1%; p = 0.082). Age-stratified analysis showed correlations with masseter pain in older patients (48.3% vs 16; p < 0.05), and with arthrosis in younger patients (57.1% vs 22.2%; p < 0.05). CONCLUSIONS: Any correlation patterns were shown between tinnitus and TMD. Age-stratified analysis suggested possible hypotheses for a symptom-specific clinical correlation that should be assessed with future research.
OBJECTIVE: To compare the prevalence of tinnitus in temporomandibular disorder (TMD) patients affected by either jaw muscle pain, temporomandibular joint (TMJ) internal derangements, or TMJ arthrosis. METHODS: The presence of self-reported tinnitus was assessed in 250 consecutive TMDpatients and correlation analysis was performed with clinical TMD signs and symptoms. RESULTS:Tinnitus prevalence in the TMD population was 30.4%. Any significant patterns of correlation were shown for the overall study group, despite a higher tinnitus prevalence in patients with (32.8%) than without masseter pain (24.8%; p = 0.176) as well as in those with (33.7%) than without TMJ arthrosis (26.1%; p = 0.082). Age-stratified analysis showed correlations with masseter pain in older patients (48.3% vs 16; p < 0.05), and with arthrosis in younger patients (57.1% vs 22.2%; p < 0.05). CONCLUSIONS: Any correlation patterns were shown between tinnitus and TMD. Age-stratified analysis suggested possible hypotheses for a symptom-specific clinical correlation that should be assessed with future research.
Authors: Annemarie van der Wal; Paul Van de Heyning; Annick Gilles; Laure Jacquemin; Vedat Topsakal; Vincent Van Rompaey; Marc Braem; Corine Mirjam Visscher; Steven Truijen; Sarah Michiels; Willem De Hertogh Journal: Front Neurosci Date: 2020-09-16 Impact factor: 4.677
Authors: Isabela Porto De Toledo; Fabiane Miron Stefani; André Luís Porporatti; Luis André Mezzomo; Marco A Peres; Carlos Flores-Mir; Graziela De Luca Canto Journal: Clin Oral Investig Date: 2016-08-10 Impact factor: 3.573
Authors: Massimo Ralli; Antonio Greco; Rosaria Turchetta; Giancarlo Altissimi; Marco de Vincentiis; Giancarlo Cianfrone Journal: J Int Med Res Date: 2017-05-28 Impact factor: 1.671
Authors: Massimo Ralli; Richard J Salvi; Antonio Greco; Rosaria Turchetta; Armando De Virgilio; Giancarlo Altissimi; Giuseppe Attanasio; Giancarlo Cianfrone; Marco de Vincentiis Journal: PLoS One Date: 2017-11-21 Impact factor: 3.240
Authors: Sarah Michiels; Annemarie Christien van der Wal; Evelien Nieste; Paul Van de Heyning; Marc Braem; Corine Visscher; Vedat Topsakal; Annick Gilles; Laure Jacquemin; Marianne Hesters; Willem De Hertogh Journal: Trials Date: 2018-10-12 Impact factor: 2.279
Authors: Annemarie Van der Wal; Sarah Michiels; Paul Van de Heyning; Marc Braem; Corine Visscher; Vedat Topsakal; Annick Gilles; Laure Jacquemin; Vincent Van Rompaey; Willem De Hertogh Journal: J Clin Med Date: 2020-03-05 Impact factor: 4.241